Shire's Lawsuit Against Nostrum Moves Forward After Judge Denies Motion

Law360, New York (July 18, 2005, 12:00 AM EDT) -- A federal judge in New Jersey has denied Nostrum Pharmaceuticals’ motion for summary judgment in Shire Pharmaceuticals Group’s patent infringement lawsuit over Nostrum’s plans to make a generic version of the epilepsy treatment Carbatrol.

Judge Mary Little Cooper’s ruling means that the lawsuit between Shire and Nostrum will continue to move toward trial. No trial date has been set by the court at this time, Shire said.

In addition to continuing the litigation between Shire and Nostrum, the court's ruling has the effect of maintaining the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.